近日,刊登在国际杂志Cancer Cell上的ー项研究报告中,来自上海交通大学医学院等机构的研究人员通过研究发现了治疗急性髓性白血病(AML)的新型治疗靶点和新型疗法,急性髓性白血病是ー种血液骨髓癌症,通常需要及时且积极的疗法对这种癌症进行治疗。研究者Wei Jia博士指出,目前我们急需新型靶点和药物来改善急性髓性白血病患者的预后情况而且我们发现患者机体中果糖的使用水平会增加,这种特殊的代谢特性就能够帮助预测患者的治疗预后情况,这项研究还为研究者提供了强大的证据来表明,利用小分子药物阻断机体果 Recently, a study published in the International Cancer Cell reported that researchers from Shanghai Jiao Tong University School of Medicine and other agencies found new therapeutic targets and new therapies for acute myeloid leukemia (AML). Acute myeloid Leukemia is a blood-borne cancer that usually requires timely and aggressive treatment of this cancer. Researcher Dr. Wei Jia pointed out that at present we urgently need new targets and drugs to improve the prognosis of patients with acute myeloid leukemia and we find that the body’s use of fructose will increase the level of this special metabolic characteristics can help predict the patient’s Treatment prognosis, this study also provides researchers with strong evidence to show that the use of small molecule drugs block the body fruit